Skip to content

Ayurvedic management for prostate enlargement

A randomised open label comparative clinical study to evaluate the role of dashamoola kashaya and varuna twak kashaya volume with special refference to benign prostatic hyperplasia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072705
Enrollment
30
Registered
2024-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms Health Condition 2: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Dr Rahul Gowda M J
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)  Age group between fifty to seventy years, irrespective of religion, caste, occupation and socioeconomic status. 2) Diagnosed case of Benign Prostatic Hyperplasia (BPH) 3) Post Void Residual volume more than 50cc.

Exclusion criteria

Exclusion criteria: 1) Prostrate Specific Antigen (PSA) levels more than 10 ng/ml. 2) Subjects with HIV, Hepatitis, Prostatic calculi, Prostatitis and Prostatic carcinoma. 3) Bladder neck stenosis. 4) Bladder neck tumours. 5) Vesical calculus. 6) Median lobe enlargement of prostate.

Design outcomes

Primary

MeasureTime frame
Reduction in Post void Residual Volume.Timepoint: after 7 days of intervention out come will be assesed

Secondary

MeasureTime frame
improvement in quality of life affected by BPHTimepoint: 14th day

Countries

India

Contacts

Public ContactDr Rahul Gowda M J

Sri Sri college of Ayuredic Science and Research

dr.swetatyagi1882@gmail.com9902521973

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026